David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
CALL
Wabtec
WAB
$50.1B
| $1.46M | ﹤0.01% |
19,800
+4,100
| +26% | +$296K |
|
2327
Ceco Environmental
CECO
$4.25B
| $1.46M | ﹤0.01% |
202,500
+42,138
| +26% | +$306K |
|
|
TACO
2328
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $1.46M | ﹤0.01% |
144,741
+72,361
| +100% | +$753K |
|
|
HES
2329
PUT
DELISTED
Hess
HES
| $1.45M | ﹤0.01% |
24,100
+9,100
| +61% | +$501K |
|
|
KRA
2330
PUT
DELISTED
Kraton Corporation
KRA
| $1.45M | ﹤0.01% |
45,000
| – | – |
|
2331
PUT
Chemours
CC
$2.35B
| $1.45M | ﹤0.01% |
38,900
-14,600
| -27% | -$531K |
|
2332
Johnson Outdoors
JOUT
$480M
| $1.44M | ﹤0.01% |
20,220
+12,924
| +177% | +$845K |
|
2333
El Pollo Loco
LOCO
$467M
| $1.44M | ﹤0.01% |
110,760
-8,584
| -7% | -$129K |
|
2334
CALL
TAL Education Group
TAL
$6.5B
| $1.44M | ﹤0.01% |
39,900
-109,700
| -73% | -$3.56M |
|
2335
CALL
Illinois Tool Works
ITW
$80B
| $1.44M | ﹤0.01% |
10,000
| – | – |
|
2336
CALL
Koppers
KOP
$862M
| $1.43M | ﹤0.01% |
+55,000
| New | +$1.29M |
|
2337
Anterix
ATEX
$1.83B
| $1.43M | ﹤0.01% |
40,554
+12,797
| +46% | +$503K |
|
2338
CALL
Universal Insurance Holdings
UVE
$1.19B
| $1.43M | ﹤0.01% |
46,000
| – | – |
|
2339
CALL
BJ's Restaurants
BJRI
$1.38B
| $1.42M | ﹤0.01% |
30,000
| – | – |
|
2340
Sensata Technologies
ST
$6.16B
| $1.41M | ﹤0.01% |
+31,378
| New | +$1.49M |
|
|
XEC
2341
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $1.41M | ﹤0.01% |
20,200
+4,100
| +25% | +$295K |
|
2342
CALL
Sea Limited
SE
$71.8B
| $1.41M | ﹤0.01% |
+60,000
| New | +$1.05M |
|
|
EEX
2343
DELISTED
Emerald Holding
EEX
| $1.41M | ﹤0.01% |
110,990
+1,700
| +2% | +$22.2K |
|
2344
Liberty Media Series A
FWONA
$23.8B
| $1.41M | ﹤0.01% |
43,251
-1,110
| -3% | -$33.6K |
|
2345
Intrepid Potash
IPI
$494M
| $1.41M | ﹤0.01% |
37,138
+30,261
| +440% | +$1.05M |
|
2346
Universal Health Services
UHS
$10.3B
| $1.41M | ﹤0.01% |
10,519
-6,635
| -39% | -$874K |
|
2347
Forte Biosciences
FBRX
$1.63B
| $1.41M | ﹤0.01% |
345
+247
| +252% | +$954K |
|
2348
Carriage Services
CSV
$548M
| $1.4M | ﹤0.01% |
72,929
+54,013
| +286% | +$1.04M |
|
2349
CALL
Affiliated Managers Group
AMG
$9.55B
| $1.4M | ﹤0.01% |
13,100
-18,600
| -59% | -$1.98M |
|
2350
CALL
eHealth
EHTH
$38.1M
| $1.4M | ﹤0.01% |
+22,500
| New | +$1.24M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.